Marty Makary has resigned as FDA commissioner, with various factors contributing to his departure, including industry pressure and possible backlash from the White House. The circumstances surrounding his resignation are not entirely clear, but it is reported to have followed a tumultuous tenure and internal friction. Makary's time as commissioner has ended, and an acting commissioner has been named.